FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method for predicting the clinical course of sarcoidosis. Substance of the method consists in analysing biopsy material of a middle lobe of the right lung. What is involved is an immunohistochemical analysis in at least 5 visual fields at magnification ×400 to measure an average myofibroblast count in the interalveolar interstitial tissue. If the derived value is more than 50, the unfavourable outcome of sarcoidosis is predicted; the value of 15 and less average myofibroblast count, the favourable outcome of sarcoidosis is predicted.
EFFECT: using the declared method enables the early prediction and detection of the group of patients not requiring a great number of additional examinations.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF GLUCOCORTICOSTEROID CLINICAL EFFECTIVENESS | 2008 |
|
RU2382364C1 |
METHOD FOR PREDICTION THE COURSE OF RESPIRATORY SARCOIDOSIS BY MORPHOLOGICAL STRUCTURE OF GRANULOMA | 2019 |
|
RU2707510C1 |
METHOD FOR EXPRESS ASSESSMENT OF X-RAY STAGE OF ACUTE SARCOIDOSIS ASSOCIATED WITH SEPTAL PANNICULITIS | 2021 |
|
RU2758811C1 |
METHOD FOR PREDICTION OF VARIABILITY OF PEMPHIGUS CLINICAL FORM | 2008 |
|
RU2386400C1 |
METHOD OF ASSESSING INFLAMMATORY PROCESS ACTIVITY IN SARCOIDOSIS | 2010 |
|
RU2423701C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE PEMPHIGUS | 2010 |
|
RU2429482C1 |
METHOD FOR DETERMINING IDIOPATHIC FIBROSING ALVEOLITIS THERAPY EFFECTIVENESS | 2004 |
|
RU2268473C1 |
METHOD OF PREDICTING COURSE OF RESPIRATORY SARCOIDOSIS | 2023 |
|
RU2810480C1 |
COMPUTER-AIDED DIAGNOSIS METHOD FOR DETERMINING PULMONARY HYPERTENSION SEVERITY | 2004 |
|
RU2269931C1 |
METHOD OF DIAGNOSTICS OF AUTOIMMUNE VIOLENT DERMATOSES | 2008 |
|
RU2352947C1 |
Authors
Dates
2015-04-27—Published
2013-11-20—Filed